140 results
Page 3 of 7
8-K
EX-99.1
nunutng9
6 Dec 22
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure
7:01am
8-K
EX-99.1
pvwyil
9 Nov 22
Biocardia Reports Third Quarter 2022 Business Highlights and Financial Results
4:07pm
8-K
EX-99.1
irro i8vjf
31 Aug 22
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial
7:00am
8-K
EX-99.1
7dr3u
24 Aug 22
BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter
7:00am
8-K
EX-99.1
2kdrjpyry 81
10 Aug 22
Biocardia Reports Second Quarter 2022 Business Highlights and Financial Results
4:06pm
8-K
EX-99.1
3juvh4y8pk
1 Aug 22
BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial
8:05am
8-K
EX-99.1
c1z9io
15 Jun 22
BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies
8:16am
8-K
EX-99.1
6p8 92eoj
11 May 22
Biocardia Reports First Quarter 2022 Business Highlights and Financial Results
4:06pm
424B5
hpteeci9nae4ywam0
12 Apr 22
Prospectus supplement for primary offering
8:01am
8-K
EX-99.1
yp4vy97m237pxus
12 Apr 22
Phase I/II Trial Initiation Expected in 3Q 2022
7:16am
8-K
EX-99.1
n319 ky71ri100xk
29 Mar 22
Biocardia Reports 2021 Financial Results and Recent Business Highlights
4:07pm
8-K
lehfcak e7zoh
22 Mar 22
BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure
8:45am
8-K
EX-99.1
2gk1721
22 Mar 22
BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure
8:45am
8-K
EX-99.1
z63 c4r7k
1 Mar 22
BioCardia Receives No Objection Letter from Health Canada, Enabling Company to Expand CardiAMP Cell Therapy Heart Failure Trial into Canada
8:15am
8-K
EX-99.1
5emney0g3 hhb3l4
14 Feb 22
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed
8:00am